Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T05:04:29.144Z Has data issue: false hasContentIssue false
  • English
  • Français

Large simple trials in psychiatry: providing reliable answers to important clinical questions

Published online by Cambridge University Press:  11 October 2011

John R. Geddes
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 14 , Issue 3 , September 2005 , pp. 122 - 126
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

AD 2000 Collaborative Group (2004). Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 383, 2105–2115.Google Scholar
Chalmers, I., Rounding, C. & Lock, K. (2003). Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. British Medical Journal 327, 1017.CrossRefGoogle ScholarPubMed
Cipriani, A., Barbui, C. & Geddes, J.R. (2005). Suicide, depression, and antidepressants. British Medical Journal 330, 373–374.Google ScholarPubMed
Fergusson, D., Doucette, S., Glass, K.C., Shapiro, S., Healy, D., Hebert, P. & Hutton, B. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 330, 396.CrossRefGoogle ScholarPubMed
Geddes, J. (2003). Generating evidence to inform policy and practice: the example of the second generation “atypical” amipsychotics. Schizophrenia Bulletin 29, 105–114.CrossRefGoogle Scholar
Geddes, J.R. & Cipriani, A. (2004). Selective serotonin reuptake inhibitors. British Medical Journal 329, 809–810.Google ScholarPubMed
Geddes, J.R., Freemantle, N., Harrison, P.J., & Bebbington, P.E. (2000). Atypical antipsychotics in the treatment of schizophrenia: systematic review and meta-regression analysis. British Medical Journal 321, 1371–1376.CrossRefGoogle Scholar
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Collaborative Group (1990). GISS1-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336, 65–71.Google Scholar
Gunnell, D. & Ashby, D. (2004). Antidepressants and suicide: what is the balance of benefit and harm. British Medical Journal 329, 34–38.Google Scholar
Gunnell, D., Saperia, J. & Ashby, D. (2005). Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. British Medical Journal 330, 385.CrossRefGoogle Scholar
Haynes, B. (1999). Can it work? Does it work? Is it worth it?. British Medical Journal 319, 652–653.CrossRefGoogle ScholarPubMed
Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7–22.CrossRefGoogle Scholar
Hotopf, M., Lewis, G. & Normand, C. (1997). Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology & Community Health 51, 354–358.CrossRefGoogle ScholarPubMed
ISIS-1 Collaborative Group (1985). Randomised trial of intravenous atenolol among 16.027 cases of suspected acute myocardial infarction. Lancet 2, 57–66.Google Scholar
ISIS-2 Collaborative Group (1988). Randomised trial of intravenous streptokinase. oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2, 349–360.Google Scholar
ISIS-3 Collaborative Group (1992). ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339, 753–770.CrossRefGoogle Scholar
ISIS-4 Collaborative Group (1995). ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4. Lancet 345, 669–685.CrossRefGoogle Scholar
Leff, J.P. & Wing, J.K. (1971). Trial of maintenance therapy in schizophrenia. British Medical Journal 3, 559–604.CrossRefGoogle ScholarPubMed
Martinez, C, Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S. & Gunnell, D. (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. British Medical Journal 330, 389.CrossRefGoogle ScholarPubMed
Medical Research Council (1948). Streptomycin treatment of pulmonary tuberculosis. British Medical Journal 769–773.Google Scholar
Medical Research Council (1965). Clinical trial of the treatment of depressive illness. British Medical Journal 1, 881–886.CrossRefGoogle Scholar
Mindham, R.H., Howland, C. & Shepherd, M. (1972). Continuation therapy with tricyclic antidepressants in depressive illness. Lancet 2, 854–855.CrossRefGoogle ScholarPubMed
National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group (1964). Phenothiazine treatment in acute schizophrenia. Archives of General Psychiatry 10, 246–261.CrossRefGoogle Scholar
Peto, R., Collins, R. & Gray, R. (1993). Large-scale randomized evidence: large, simple trials and overviews of trials. Annals of New York Academy of Science 703, 314–340.Google ScholarPubMed
Prescott, R.J., Counsell, C.E., Gillespie, W.J., Grant, A.M., Russell, I.T., Kiauka, S., Colthart, I.R., Ross, S., Shepherd, S.M. & Russell, D. (1999). Factors that limit the quality, number and progress of randomised controlled trials. Health Technology Assessment 3, 1–143.CrossRefGoogle ScholarPubMed
Prien, R.F., Caffey, E.M. Jr & Klett, C.J. (1973a). Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Archives of General Psychiatry 28, 337–341.CrossRefGoogle ScholarPubMed
Prien, R.F., Klett, C.J. & Caffey, E.M.J. (1973b). Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Archives of General Psychiatry 29, 420–425.CrossRefGoogle ScholarPubMed
Schwartz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 20, 637–648.CrossRefGoogle Scholar
Thornley, B. & Adams, C. (1998). Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal 317, 1181–1184.CrossRefGoogle ScholarPubMed
Yusuf, S., Collins, R. & Peto, R. (1984). Why do we need some large, simple randomized trials? Statistics in Medicine 3, 409–422.CrossRefGoogle ScholarPubMed